Clinical Trial Update: Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. [Phase 3]

View source ↗

Summary

Phase 3 global trial evaluating everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in advanced hepatocellular carcinoma; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Afinitor (everolimus) (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2014-10-27